We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$56.1B
AUM Growth
+$5.03B
Cap. Flow
+$134M
Cap. Flow %
0.24%
Top 10 Hldgs %
27.78%
Holding
1,430
New
30
Increased
515
Reduced
358
Closed
37

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$196M
2
HD icon
Home Depot
HD
+$72.2M
3
GEV icon
GE Vernova
GEV
+$63.1M
4
DB icon
Deutsche Bank
DB
+$58.6M
5
ULS icon
UL Solutions
ULS
+$49.5M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.5M
2
C icon
Citigroup
C
+$49.4M
3
BALL icon
Ball Corp
BALL
+$48.4M
4
FAST icon
Fastenal
FAST
+$43.5M
5
CVX icon
Chevron
CVX
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 27.14%
2 Healthcare 14.26%
3 Financials 12.06%
4 Industrials 10.38%
5 Communication Services 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBRX icon
976
ImmunityBio
IBRX
$7.94B
$525K ﹤0.01%
196,200
-8,892
-4% -$23.9K
PRI icon
977
Primerica
PRI
$9.65B
$525K ﹤0.01%
1,960
WMK icon
978
Weis Markets
WMK
$1.78B
$517K ﹤0.01%
7,416
CLDX icon
979
Celldex Therapeutics
CLDX
$3.37B
$514K ﹤0.01%
25,000
SHG icon
980
Shinhan Financial Group
SHG
$34.8B
$512K ﹤0.01%
11,779
ALXO icon
981
ALX Oncology
ALXO
$285M
$508K ﹤0.01%
41,000
BEKE icon
982
KE Holdings
BEKE
$19.5B
$506K ﹤0.01%
27,637
+735
+3% +$14.1K
UE icon
983
Urban Edge Properties
UE
$2.75B
$504K ﹤0.01%
26,852
MAN icon
984
ManpowerGroup
MAN
$2.63B
$502K ﹤0.01%
12,438
TNGX icon
985
Tango Therapeutics
TNGX
$4.51B
$502K ﹤0.01%
60,000
DRH icon
986
Diamondrock Hospitality Co
DRH
$2.48B
$486K ﹤0.01%
63,235
ESRT icon
987
Empire State Realty Trust
ESRT
$803M
$484K ﹤0.01%
63,450
POWI icon
988
Power Integrations
POWI
$3.46B
$482K ﹤0.01%
8,622
ATMU icon
989
Atmus Filtration Technologies
ATMU
$4.05B
$479K ﹤0.01%
+14,256
New +$509K
AMPH icon
990
Amphastar Pharmaceuticals
AMPH
$864M
$475K ﹤0.01%
20,848
NSIT icon
991
Insight Enterprises
NSIT
$4.54B
$474K ﹤0.01%
3,529
CVNA icon
992
Carvana
CVNA
$81.5B
$472K ﹤0.01%
7,430
WS icon
993
Worthington Steel
WS
$1.94B
$471K ﹤0.01%
14,591
+13,545
+1,295% +$349K
GRFS
994
Grifois
GRFS
$5.48B
$464K ﹤0.01%
50,000
CIB icon
995
Grupo Cibest SA
CIB
$21.7B
$461K ﹤0.01%
+12,593
New +$523K
IMCR icon
996
Immunocore
IMCR
$1.73B
$461K ﹤0.01%
15,000
CVAC
997
DELISTED
CureVac
CVAC
$458K ﹤0.01%
85,642
LPX icon
998
Louisiana-Pacific
LPX
$5.2B
$458K ﹤0.01%
5,254
-1,578
-23% -$140K
CASH icon
999
Pathward Financial
CASH
$1.81B
$454K ﹤0.01%
5,646
IVT icon
1000
InvenTrust Properties
IVT
$2.56B
$452K ﹤0.01%
16,310

Similar funds

DekaBank Deutsche Girozentrale's Q2 2025 Portfolio in Review

As of Q2 2025, DekaBank Deutsche Girozentrale held 1,430 positions worth $56.1B, up 9.8% from $51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 4.7%. DekaBank Deutsche Girozentrale opened 30 new positions and exited 37, leaving the 1,430-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • DekaBank Deutsche Girozentrale's largest Q2 2025 buy was GE Vernova: 151,508 shares worth $79.9M.
  • DekaBank Deutsche Girozentrale added most to Apple in Q2 2025, an estimated $196M increase.
  • DekaBank Deutsche Girozentrale's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $51.5M.
  • DekaBank Deutsche Girozentrale fully exited Aspen Technology Inc in Q2 2025, selling an estimated $8.02M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 28% of its $56.1B portfolio in Q2 2025.
  • DekaBank Deutsche Girozentrale opened 30 new positions and closed 37 in Q2 2025.
  • DekaBank Deutsche Girozentrale's portfolio value rose 9.8% quarter-over-quarter to $56.1B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2025, filed 30 Jul 2025.